SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Xenova (XNVA) -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (93)11/16/2004 11:37:08 AM
From: Extra Pale  Respond to of 173
 
previously, 944 was considered by mlnm to be high priority. perhaps with phase 1 data in hand, xnva will be able to negotiate a new more favorable partnership. (rationalizing buying more, already believe xnva undervalued given number of programs)



To: keokalani'nui who wrote (93)11/16/2004 3:02:28 PM
From: nigel bates  Respond to of 173
 
mlnm is turning back x944 too. That was unexpected.

Perhaps not entirely, as it stopped being talked about in PRs - after having described it as high priority...

Having topsliced a while back, I never found sufficient reason to sell more (dammit). Am hanging on to what I have.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News